| I-69 Jingxian Chen Pharmacokinetics Optimization of Phase 2b/3 Study in Infants to Support the Development an RSV Monoclonal Antibody (MK-1654) |
| I-70 Romain Leroux New features in PFIM for optimal design in nonlinear mixed effects models using the S4 object system in R |
| I-71 Claude Magnard Simulx-GUI: a flexible, fast and user-friendly application for simulations |
| I-72 Yuanxi Zou A novel approach to evaluate the design of pediatric PK studies focused on accurate dose selection |
